Browse Category

Mergers & Acquisitions News 22 December 2025 - 23 December 2025

Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

London-listed Anglo American plc is ending 2025 with its investment story compressed into two big levers: a once-in-a-generation copper market and a once-in-a-generation corporate reshuffle. On December 23, those levers are both moving. The company has published provisional 2026 dividend timetables, while the proposed Anglo‑Teck “merger of equals” has cleared major procedural and political hurdles in Canada—yet still faces the final, fussy gatekeepers of global competition and regulatory approvals. At the same time, copper is flirting with the $12,000/ton level amid supply disruptions and tariff-driven distortions that have split the market into “metal-rich” and “metal-starved” regions. Investing.com+1 What follows is
BP PLC Stock on Dec. 23, 2025: Share Price, New CEO Meg O’Neill, Castrol Sale Talks, Buybacks, and 2026 Oil Outlook

BP PLC Stock on Dec. 23, 2025: Share Price, New CEO Meg O’Neill, Castrol Sale Talks, Buybacks, and 2026 Oil Outlook

BP PLC stock is ending 2025 with a familiar mix of Big Oil fundamentals and BP-specific drama: a surprise leadership reset, a high-stakes divestment agenda (with Castrol at the center), and a market that’s trying to price 2026 oil demand against an oversupplied-looking crude backdrop. As of Tuesday, December 23, 2025, investors are digesting what BP’s board appears to be signaling: “more discipline, fewer detours.” The big question for BP shares (LSE: BP. / NYSE: BP) is whether that message translates into higher cash flow, lower net debt, and steadier shareholder returns—or simply another chapter in the company’s multi-year strategic
Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Dec. 22, 2025 — Trump Media & Technology Group Corp. (Nasdaq / NYSE Texas: DJT) is back in its natural habitat: extreme volatility. After rocketing higher late last week on news of a surprise pivot into nuclear fusion, DJT stock dropped sharply on Monday, Dec. 22, giving back a meaningful portion of those gains. Barron’s As of 18:43 UTC on Dec. 22, DJT traded at $14.51, down $1.58 (-9.82%) from the prior close, with an intraday range of $14.325 to $17.13 on volume of 27.35 million shares. What’s driving the move is not a new ad product at Truth Social,
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

December 22, 2025 — Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) traded higher Monday as the company’s takeover battle intensified, with Paramount Skydance revising its hostile bid and Netflix disclosing fresh financing arrangements tied to its agreed deal with Warner’s studio-and-streaming assets. Nasdaq+2Reuters+2 WBD shares were recently around $28.70, after ranging between $27.78 and $29.31 in Monday’s session, as investors weighed the value of Paramount’s $30-per-share all-cash proposal against the certainty, structure, and regulatory path of the Netflix transaction. Reuters+1 Why Warner Bros. Discovery stock is moving on Dec. 22, 2025 Two headline developments hit the market
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion (including debt). Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2 With the deal now public, the CWAN story shifts from the usual quarterly beat/miss drama to a more deal-driven narrative: merger timelines, regulatory approvals, a “go-shop” window for competing bids, and whether the stock trades at (or below) the
Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings Inc. (NYSE: KRMN) stock is having a loud Monday. In midday trading on December 22, 2025, KRMN stock jumped roughly 8%–9% into the high-$70s, putting the aerospace-and-defense newcomer among the market’s notable winners as risk appetite improved and small caps outperformed. StockAnalysis+2Benzinga+2 So what’s actually behind the move—and what do the newest forecasts and analyses imply for where Karman Holdings stock could go next? Below is a comprehensive snapshot of today’s news and analysis (Dec. 22, 2025), plus the freshest Wall Street outlooks that are shaping the narrative around KRMN right now. KRMN stock today: price, momentum, and
Warner Bros. Discovery Stock (WBD) Today: Paramount Adds Larry Ellison’s $40.4B Guarantee, Netflix Locks In Deal Financing — What It Means for Shares (Dec. 22, 2025)

Warner Bros. Discovery Stock (WBD) Today: Paramount Adds Larry Ellison’s $40.4B Guarantee, Netflix Locks In Deal Financing — What It Means for Shares (Dec. 22, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) stock is trading like a referendum on one question: which bidder (if any) ultimately wins one of the biggest media takeovers in history. As of Dec. 22, 2025, WBD shares were last at $27.77, after swinging between $27.07 and $29.31 in a volatile session. The day’s catalyst is straightforward: Paramount Skydance doubled down on its hostile takeover attempt with a major financing upgrade—an “irrevocable personal guarantee” from Oracle co-founder Larry Ellison covering $40.4 billion of equity financing—while Netflix moved to strengthen its own bid by refinancing a large piece of the bridge funding backing
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin Pharmaceutical has agreed to pay. Investing.com+1 That tight range is the market’s way of saying: “We believe the deal is real, but not free money.” The remaining gap between today’s trading price and the $14.50 cash consideration reflects the time value of waiting, plus the risk (however small) that something delays or disrupts closing. Below is a full, publication-ready breakdown
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

Dec. 22, 2025 — ProPhase Labs, Inc. (NASDAQ: PRPH) is hitting one of the most consequential “inflection points” a micro-cap stock can face: a Nasdaq compliance deadline, a reverse stock split that reshapes how the ticker trades, and a newly announced non-binding reverse merger proposal that could dramatically change what ProPhase Labs is going forward. Reuters+3NASDAQ Trader+3ProPhase Labs, Inc.+3 In plain English: PRPH investors are watching two parallel storylines unfold at once—(1) staying listed and (2) potentially being “re-made” via a reverse merger with Europe-based Advanced Biological Laboratories S.A. (ABL). ProPhase Labs, Inc.+2Euronext Live+2 Why ProPhase Labs stock is in
Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18 on Dec. 22, the market is now pricing FOLD mostly on closing probability and timing, not clinical catalysts. Investing.com+1 That change in narrative is already visible in analyst actions dated 22.12.2025: TD Cowen downgraded Amicus to Hold and reset its target to $14.50, essentially treating the stock as a merger-arbitrage position rather than a standalone biotech. Investing.com Below is the
Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Updated for Dec. 22, 2025 — Luminar Technologies, Inc. (NASDAQ: LAZR) is in the middle of a court-supervised restructuring that has turned the stock into a high-volatility, headline-driven trade. The company filed for Chapter 11 bankruptcy on Dec. 15, lined up a $110 million all-cash deal to sell its photonics subsidiary, and is now facing an imminent Nasdaq delisting—while the share price whipsaws on extraordinary volume. Luminar Technologies, Inc.+2Luminar Technologies, Inc.+2 What matters for investors on Dec. 22 isn’t a typical earnings “beat or miss.” It’s the bankruptcy timeline, the auction process, and the harsh reality of capital structure math:
Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Corporation plc (NYSE: ETN) heads into the holiday-shortened trading week with investors weighing two competing forces: a powerful multi-year “grid-to-chip” demand story tied to AI data centers and electrification, and near-term questions about valuation, cyclical end-markets, and deal execution. As of the latest available pricing (Friday’s close), ETN traded around $317.80. In the most notable move of the past week, Eaton shares fell 4.28% on Wednesday, December 17, closing at $315.82, with trading volume reported well above the recent average—an attention-getting signal heading into a low-liquidity, year-end tape. MarketWatch Below is a week-ahead briefing built from the most recent
1 3 4 5 6 7 34

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop